The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-25
DOI
10.3389/fimmu.2018.02159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CXCL5 Facilitates Melanoma Cell–Neutrophil Interaction and Lymph Node Metastasis
- (2018) Ana Soler-Cardona et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models
- (2018) Nicole Salazar et al. MOLECULAR THERAPY
- CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
- (2018) Yang Zhang et al. OncoTargets and Therapy
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
- (2018) Mieke Metzemaekers et al. Frontiers in Immunology
- Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
- (2018) Manja Idorn et al. OncoImmunology
- Targeting both tumour-associated CXCR2+neutrophils and CCR2+macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
- (2017) Timothy M Nywening et al. GUT
- The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression
- (2017) Ya Cao et al. IMMUNOLOGICAL INVESTIGATIONS
- Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages
- (2017) Francesca Bellora et al. JOURNAL OF IMMUNOLOGY
- A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer
- (2017) Ravi Salgia et al. LUNG CANCER
- A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
- (2017) Z Xiang et al. ONCOGENE
- Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
- (2017) Jingkun Zhao et al. Oncotarget
- Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
- (2017) Larissa Kistner et al. Oncotarget
- CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients
- (2017) C Windmüller et al. Oncogenesis
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- (2016) Holger Bronger et al. BRITISH JOURNAL OF CANCER
- Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
- (2016) C. Alfaro et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
- (2016) Yana G. Najjar et al. CLINICAL CANCER RESEARCH
- CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
- (2016) Chang Xian Li et al. JOURNAL OF HEPATOLOGY
- Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+T Cell Migration into Tumors
- (2016) Zinal S. Chheda et al. JOURNAL OF IMMUNOLOGY
- Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
- (2016) B. Behnam Azad et al. JOURNAL OF NUCLEAR MEDICINE
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
- (2016) S Lefort et al. ONCOGENE
- CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
- (2016) T. Chao et al. Cancer Immunology Research
- The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
- (2016) Shuo Zhang et al. PLoS One
- CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma
- (2015) Yusuke Sato et al. ANNALS OF SURGICAL ONCOLOGY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity
- (2015) Guiquan Zhu et al. Oncotarget
- STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
- (2015) C. Yue et al. Cancer Immunology Research
- Chemokine Receptor Expression on Normal Blood CD56+NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population
- (2015) Margarida Lima et al. Journal of Immunology Research
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment
- (2015) Kar Wai Tan et al. OncoImmunology
- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
- (2014) Zhigang Zhang et al. BMC CANCER
- CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
- (2014) Erik Wennerberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
- (2014) Talib Hassan Ali et al. Nature Communications
- The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases
- (2014) Lianyu Chen et al. Scientific Reports
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non–Small Cell Lung Cancer Cells
- (2013) Young H. Choi et al. MOLECULAR CANCER RESEARCH
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis
- (2013) Jingxun Wu et al. TUMOR BIOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
- (2012) P. Saintigny et al. CANCER RESEARCH
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow
- (2011) G. Sciume et al. BLOOD
- Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
- (2011) K. Mayol et al. BLOOD
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
- (2011) N. Halama et al. CLINICAL CANCER RESEARCH
- Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
- (2011) Benjamin Toh et al. PLOS BIOLOGY
- CXCL12-CXCR4 chemokine signaling is essential for NK-cell development in adult mice
- (2010) M. Noda et al. BLOOD
- CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells
- (2010) S Amatschek et al. BRITISH JOURNAL OF CANCER
- Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
- (2010) W. Peng et al. CLINICAL CANCER RESEARCH
- CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes
- (2010) R. D. Berahovich et al. JOURNAL OF IMMUNOLOGY
- Foxp3+ IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
- (2010) Shaobo Yang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis
- (2010) Fabio Morandi et al. PLoS One
- Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
- (2009) B Cambien et al. BRITISH JOURNAL OF CANCER
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
- (2009) Emmanuelle Pradelli et al. INTERNATIONAL JOURNAL OF CANCER
- CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets
- (2008) G. Bernardini et al. BLOOD
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro
- (2008) Ji-Kun Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Chemokine Receptor CXCR3 is an Independent Prognostic Factor in Patients With Localized Clear Cell Renal Cell Carcinoma
- (2007) Tobias Klatte et al. JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now